Sponsor Pipeline

Insud Pharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
2
Phase 3
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-31 NCT07739589 A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl… Phase 4 Completed
Active Trials by Phase
Phase 4
1
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05303636 LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density… Change in Bone Mineral Density Active, Not Recruiting
Phase 3
NCT06282315 Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness Soil-Transmitted Helminths Recruiting
NCT04024163 Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate… Chagas Disease Active, Not Recruiting
Phase 2
NCT06968481 Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage Post Partum Hemorrhage Not Yet Recruiting
Get alerts when Insud Pharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free